Fentanyl Cit 0.05mg/ml Inj, 2ml
Overview
What is this medicine?
How to Use This Medicine
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.
In the event that you miss a dose, contact your doctor promptly to receive guidance on the appropriate course of action.
Lifestyle & Tips
- Avoid alcohol and other sedating medications unless specifically approved by your doctor.
- Do not drive or operate heavy machinery after receiving fentanyl, as it can cause drowsiness and impair your ability to react.
- Follow all instructions from your healthcare provider regarding activity restrictions after receiving fentanyl.
Available Forms & Alternatives
Available Strengths:
- Fentanyl 25mcg/hr Patch
- Fentanyl 50mcg/hr Patch
- Fentanyl 75mcg/hr Patch
- Fentanyl 100mcg/hr Patch
- Fentanyl Cit 0.05mg/ml Inj, 20ml
- Fentanyl Cit 0.05mg/ml Inj, 2ml
- Fentanyl Cit 0.05mg/ml Inj, 50ml
- Fentanyl Cit 0.05mg/ml Inj, 5ml
- Fentanyl Cit 800mcg Oral Transmcsl
- Fentanyl Cit 1200mcg Oral Transmcsl
- Fentanyl Cit 600mcg Oral Transmcsl
- Fentanyl Cit 1600mcg Oral Transmcsl
- Fentanyl Cit 400mcg Oral Transmcsl
- Fentanyl Cit 200mcg Oral Transmcsl
- Fentanyl 62.5mcg/hr Patch
- Fentanyl 87.5mcg/hr Patch
- Fentanyl Cit 600mcg Oraltransmcsl
- Fentanyl Cit 800mcg Oral Transmcsl
- Fentanyl Cit 1600mcg Oral Transmcsl
- Fentanyl Cit 100mcg Tablets
- Fentanyl Cit 200mcg Tablets
- Fentanyl 37.5mcg/hr Patch
- Fentanyl 62.5mcg/hr Patch
- Fentanyl Cit 50mcg/ml Pf Inj, 1ml
- Fentanyl 12mcg/hr Patch
- Fentanyl Cit 50mcg/1ml Inj, 10ml
- Fentanyl Cit 100mcg/2ml Pf Inj, 2ml
- Fentanyl Cit 25mcg/0.5ml Pf Inj
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Seek Immediate Medical Attention If You Experience:
- Slow or shallow breathing
- Extreme drowsiness or difficulty waking up
- Dizziness or lightheadedness
- Confusion
- Bluish lips or fingernails
- Severe constipation or difficulty urinating
- Signs of allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
Certain health conditions, including:
+ Respiratory problems, such as asthma, breathing difficulties, or sleep apnea
+ Elevated carbon dioxide levels in the blood
+ Stomach or bowel obstruction or narrowing
Kidney or liver disease
Recent use (within the last 14 days) of specific medications for depression or Parkinson's disease, including isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may increase the risk of severely high blood pressure
* Current use of certain medications, such as buprenorphine, butorphanol, linezolid, methylene blue, nalbuphine, or pentazocine
This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help determine whether it is safe to take this medication in conjunction with your other treatments and health status. Never start, stop, or adjust the dosage of any medication without consulting your doctor.
Precautions & Cautions
It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.
Caution with Daily Activities
Until you know how this medication affects you, avoid driving and other tasks that require alertness. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying down position, and be cautious when climbing stairs.
Tolerance and Dependence
Long-term or high-dose use of this medication may lead to tolerance, where the medication becomes less effective, and higher doses may be needed to achieve the same effect. If you experience a decrease in the medication's effectiveness, contact your doctor. Do not take more than the prescribed dose.
Additionally, regular use of opioid medications like this one can cause dependence. If you need to lower your dose or stop taking this medication, consult your doctor first, as sudden changes may lead to withdrawal or other severe problems. Follow your doctor's instructions carefully, and report any increased pain, mood changes, suicidal thoughts, or other adverse effects.
Safe Use
Do not exceed the prescribed dose, frequency, or duration of treatment, as this may increase the risk of severe side effects. Avoid taking this medication with other strong pain medications or using a pain patch without consulting your doctor first.
If your pain worsens, you become more sensitive to pain, or you experience new pain after taking this medication, contact your doctor immediately. Do not take more than the prescribed dose.
Interactions and Contraindications
If you consume grapefruit juice or eat grapefruit regularly, discuss this with your doctor. Do not take this medication with alcohol or products containing alcohol, as this may lead to unsafe and potentially fatal effects.
Seizure Risk
This medication may increase the risk of seizures in some individuals, including those with a history of seizures. Consult your doctor to determine if you are at a higher risk of seizures while taking this medication.
Hormonal Effects
Long-term use of opioid medications like this one may lead to decreased sex hormone levels. If you experience a decrease in libido, fertility problems, irregular menstrual periods, or ejaculation problems, contact your doctor.
Special Precautions
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
Breastfeeding
If you are breastfeeding, inform your doctor, as this medication passes into breast milk and may harm your baby. Seek medical attention immediately if your baby appears overly sleepy, limp, or has breathing difficulties.
Overdose Information
Overdose Symptoms:
- Severe respiratory depression (extremely slow or stopped breathing)
- Extreme somnolence progressing to stupor or coma
- Pinpoint pupils (miosis)
- Skeletal muscle flaccidity
- Cold, clammy skin
- Bradycardia
- Hypotension
- Circulatory collapse
- Death
What to Do:
Immediate medical attention is required. Call 911 or emergency services. Naloxone (Narcan) is the antidote for opioid overdose. Management includes establishing a patent airway, providing assisted or controlled ventilation, and administering naloxone. Call 1-800-222-1222 for Poison Control.
Drug Interactions
Contraindicated Interactions
- Concomitant use with strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, nefazodone) in patients not receiving chronic opioid therapy, due to risk of fatal respiratory depression.
- Concomitant use with monoamine oxidase inhibitors (MAOIs) or within 14 days of MAOI discontinuation, due to risk of severe, unpredictable reactions including serotonin syndrome.
Major Interactions
- Benzodiazepines and other CNS depressants (e.g., other opioids, sedatives, hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, alcohol): Increased risk of profound sedation, respiratory depression, coma, and death.
- Serotonergic drugs (e.g., SSRIs, SNRIs, TCAs, triptans, mirtazapine, tramadol): Risk of serotonin syndrome.
- Mixed agonist/antagonist opioids (e.g., butorphanol, nalbuphine, pentazocine): May reduce fentanyl's analgesic effect and/or precipitate withdrawal symptoms.
- Partial agonist opioids (e.g., buprenorphine): May reduce fentanyl's analgesic effect and/or precipitate withdrawal symptoms.
Moderate Interactions
- Moderate CYP3A4 inhibitors (e.g., erythromycin, diltiazem, verapamil, fluconazole): Increased fentanyl plasma concentrations, leading to increased opioid effects.
- CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin, St. John's Wort): Decreased fentanyl plasma concentrations, leading to reduced efficacy or withdrawal symptoms.
- Anticholinergic drugs: Increased risk of urinary retention and/or severe constipation, which may lead to paralytic ileus.
Minor Interactions
- Not available
Monitoring
Baseline Monitoring
Rationale: To assess baseline respiratory function and risk of depression.
Timing: Prior to administration
Rationale: To assess baseline oxygenation.
Timing: Prior to administration
Rationale: To assess baseline neurological status and risk of over-sedation.
Timing: Prior to administration
Rationale: To assess baseline cardiovascular status.
Timing: Prior to administration
Rationale: To establish baseline pain level for efficacy assessment.
Timing: Prior to administration
Routine Monitoring
Frequency: Continuously during and immediately after administration; frequently thereafter until stable.
Target: 12-20 breaths/min (adults), age-appropriate for pediatric
Action Threshold: <10 breaths/min (adults) or significant decrease from baseline, shallow breathing, or apnea
Frequency: Continuously during and immediately after administration; frequently thereafter until stable.
Target: >92-94% on room air
Action Threshold: <90% or significant decrease from baseline
Frequency: Continuously during and immediately after administration; frequently thereafter until stable.
Target: Alert to easily arousable
Action Threshold: Unarousable, somnolent, or difficult to arouse
Frequency: Frequently during and after administration.
Target: Within patient's normal range
Action Threshold: Significant hypotension or bradycardia
Frequency: As needed, typically every 1-2 hours initially, then less frequently.
Target: Patient-specific goal (e.g., <4/10)
Action Threshold: Uncontrolled pain requiring additional intervention
Symptom Monitoring
- Respiratory depression (slow, shallow breathing, cyanosis)
- Excessive sedation/somnolence
- Hypotension
- Bradycardia
- Nausea/vomiting
- Constipation
- Pruritus
- Muscle rigidity (especially chest wall)
- Serotonin syndrome (agitation, hallucinations, tachycardia, fever, sweating, muscle rigidity, tremor, incoordination, nausea, vomiting, diarrhea)
Special Patient Groups
Pregnancy
Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Prolonged use during pregnancy can result in neonatal opioid withdrawal syndrome (NOWS), which may be life-threatening if not recognized and treated.
Trimester-Specific Risks:
Lactation
Fentanyl is excreted in breast milk. Monitor breastfed infants for signs of sedation and/or respiratory depression (e.g., increased sleepiness, difficulty breastfeeding, limpness, shallow breathing). A single dose is generally considered compatible with breastfeeding, but caution is advised.
Pediatric Use
Use with extreme caution, especially in neonates and infants, due to increased sensitivity to respiratory depression. Dosing must be individualized and carefully titrated. Close monitoring of respiratory status is essential.
Geriatric Use
Elderly patients may be more sensitive to the effects of fentanyl, particularly respiratory depression. Consider lower initial doses and slower titration. Monitor closely for adverse effects, including respiratory depression, sedation, and hypotension.
Clinical Information
Clinical Pearls
- Fentanyl is extremely potent; even small errors in dosing can be fatal. Always double-check calculations and concentrations.
- Rapid IV administration can cause chest wall rigidity, which may impair ventilation. Administer slowly over 1-2 minutes.
- Be prepared to manage respiratory depression with naloxone and ventilatory support.
- Tolerance and physical dependence can develop with prolonged use, even at therapeutic doses.
- The short duration of action of IV fentanyl means repeated doses may be needed for sustained analgesia, increasing the risk of cumulative effects and respiratory depression.
- Patients with head injury or increased intracranial pressure should receive fentanyl with extreme caution due to the risk of increased ICP and masking of neurological signs.
Alternative Therapies
- Morphine
- Hydromorphone
- Sufentanil
- Remifentanil
- Meperidine (less common due to side effects)
- Non-opioid analgesics (e.g., NSAIDs, acetaminophen) for less severe pain or as adjuncts.
Cost & Coverage
General Drug Facts
In the event of an overdose, a medication called naloxone can be administered to help treat the condition. Consult your doctor or pharmacist about obtaining and using naloxone. If you suspect an overdose has occurred, seek immediate medical attention, even if naloxone has been administered. Be prepared to provide information about the overdose, including the substance taken, the amount, and the time it occurred. In case of a suspected overdose, contact your local poison control center or seek emergency medical care right away, and be ready to provide details about the incident.